TFA Therapeutics, Inc. (RAJAF) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $3.2K | -91.4% |
| 2024 | $37.3K | +61.4% |
| 2023 | $23.1K | +248.6% |
| 2022 | $6.6K | -93.4% |
| 2021 | $99.7K | +33806.1% |
| 2020 | $294 | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $3.2K | -91.4% |
| 2024 | $37.3K | +61.4% |
| 2023 | $23.1K | +248.6% |
| 2022 | $6.6K | -93.4% |
| 2021 | $99.7K | +33806.1% |
| 2020 | $294 | — |